Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

300363.SZ Gross Margin

The Gross Margin of Porton Pharma Solutions Ltd (300363.SZ) is 23.33%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

300363.SZ Gross Margin - Historical Value
Date Value
2024-12-31 23.33%
2023-12-31 39.19%
2022-12-31 51.69%
2021-12-31 40.70%
2020-12-31 40.43%
2019-12-31 35.85%
2018-12-31 33.07%
2017-12-31 36.33%
2016-12-31 37.80%
2015-12-31 32.22%
300363.SZ Gross Margin - Peers Comparison
Ticker Name Value
000623.SZ Jilin Aodong Pharmaceutical Group Co Ltd 48.73%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 88.91%
300119.SZ Tianjin Ringpu Bio-Technology Co Ltd 40.73%
300702.SZ Zhejiang Tianyu Pharmaceutical Co Ltd 33.63%
600867.SS Tonghua Dongbao Pharmaceutical Co Ltd 79.79%
002755.SZ Beijing Aosaikang Pharmaceutical Co Ltd 80.77%
603456.SS Zhejiang Jiuzhou Pharmaceutical Co Ltd 30.89%
603718.SS Shanghai Hile Bio-Technology Co Ltd 48.68%
688526.SS Wuhan Keqian Biology Co Ltd 70.61%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 23.12%
688505.SS Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd 91.05%
000423.SZ Dong-E-E-Jiao Co Ltd 72.57%
2096.HK Simcere Pharmaceutical Group Ltd 80.25%
300357.SZ Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 95.26%
002287.SZ Tibet Cheezheng Tibetan Medicine Co Ltd 84.12%
002332.SZ Zhejiang Xianju Pharmaceutical Co Ltd 52.18%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.05%
460.HK Sihuan Pharmaceutical Holdings Group Ltd 65.32%
600195.SS China Animal Husbandry Industry Co Ltd 16.35%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd 89.12%
002019.SZ Yifan Pharmaceutical Co Ltd 47.42%
002399.SZ Shenzhen Hepalink Pharmaceutical Group Co Ltd 33.10%
002626.SZ Xiamen Kingdomway Group Co 38.33%
300630.SZ Hainan Poly Pharm Co Ltd 72.65%
603567.SS HeiLongJiang ZBD Pharmaceutical Co Ltd 42.01%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd 9.13%
002424.SZ Guizhou Bailing Group Pharmaceutical Co Ltd 54.19%
1477.HK Ocumension Therapeutics 53.93%